Key result
Periprocedural bradycardia, along with age, thrombus aspiration, neutrophil percentage, and total vessel occlusion, was identified as an independent risk factor for coronary microvascular obstruction during primary percutaneous coronary intervention.
Why the study?
Coronary microvascular obstruction or no-reflow (CMVO/NR) predicts long-term mortality after primary PCI for STEMI, prompting the need to identify its risk factors.
Observational (n=2,384)
No
Age, periprocedural bradycardia, thrombus aspiration, neutrophil percentage, and total occlusion of the culprit vessel are independent risk factors for no-reflow during primary PCI for STEMI.
Answers are grounded in this paper and cite their sources.
May refine post-PPCI risk stratification in STEMI; leaves open causal validation and targeted interventions.
Background Coronary microvascular obstruction /no-reflow(CMVO/NR) is a predictor of long-term mortality in survivors of ST elevation myocardial infarction (STEMI) underwent primary percutaneous coronary intervention (PPCI). Objective To identify risk factors of CMVO/NR. Methods Totally 2384 STEMI patients treated with PPCI were divided into two groups according to thrombolysis in myocardial infarction(TIMI) flow grade:CMVO/NR group(246cases, TIMI 0-2 grade) and control group(2138 cases, TIMI 3 grade). We used univariable and multivariable logistic regression to identify risk factors of CMVO/NR. Results A frequency of CMVO/NR was 10.3%(246/2384). Logistic regression analysis showed that the differences between the two groups in age(unadjusted odds ratios [OR] 1.032; 95% CI, 1.02 to 1.045; adjusted OR 1.032; 95% CI, 1.02 to 1.046; P <0.001), periprocedural bradycardia (unadjusted OR 2.357; 95% CI, 1.752 to 3.171; adjusted OR1.818; 95% CI, 1.338 to 2.471; P <0.001),using thrombus aspirationdevices during operation (unadjusted OR 2.489; 95% CI, 1.815 to 3.414; adjusted OR1.835; 95% CI, 1.291 to 2.606; P =0.001), neutrophil percentage (unadjusted OR 1.028; 95% CI, 1.014 to 1.042; adjusted OR1.022; 95% CI, 1.008 to 1.036; P =0.002), and completely block of culprit vessel (unadjusted OR 2.626; 95% CI, 1.85 to 3.728; adjusted-OR 1.656;95% CI, 1.119 to 2.45; P =0.012) were statistically significant (P <0. 05). The area under the receiver operating characteristic curve was 0.6896. Conclusions Age, periprocedural bradycardia, using thrombus aspirationdevices during operation, neutrophil percentage, and completely block of culprit vessel may be independent risk factors for predicting CMVO/NR. We registered this study with WHO International Clinical Trials Registry Platform (ICTRP) (registration number: ChiCTR1900023213; registered date: 16 May 2019). http://www.chictr.org.cn/edit.aspx?pid=39057&htm=4 .
No takes yet. Share an insight, caveat, or question.
Li et al. (2020) conducted an observational in ST elevation myocardial infarction (STEMI) (n=2,384). Periprocedural bradycardia vs. No periprocedural bradycardia was evaluated on Coronary microvascular obstruction/no-reflow (CMVO/NR) defined as TIMI flow grade 0-2 (adjusted OR 1.818, 95% CI 1.338 to 2.471, p=<0.001). Periprocedural bradycardia, along with age, thrombus aspiration, neutrophil percentage, and total vessel occlusion, was identified as an independent risk factor for coronary microvascular obstruction during primary percutaneous coronary intervention.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: